Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Argenx Se ADR (NQ: ARGX )

500.87 -4.96 (-0.98%)
Streaming Delayed Price Updated: 9:36 AM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,712
Open 504.67
Bid (Size) 500.50 (1)
Ask (Size) 501.34 (1)
Prev. Close 505.83
Today's Range 500.87 - 504.67
52wk Range 333.07 - 550.76
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis
From argenx SE
Via GlobeNewswire
The Latest Analyst Ratings for argenx
Via Benzinga

Performance

YTD
+33.99%
+33.99%
1 Month
-1.22%
-1.22%
3 Month
+29.19%
+29.19%
6 Month
+38.42%
+38.42%
1 Year
+45.71%
+45.71%

More News

Read More
This New S&P 500 Entrant Leads 5 Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
Via Benzinga
argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis
From argenx SE
Via GlobeNewswire
What 20 Analyst Ratings Have To Say About argenx
Via Benzinga
Here's How Much $1000 Invested In argenx 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years
Via Benzinga
argenx to Present at Upcoming Investor Conferences
From argenx SE
Via GlobeNewswire
Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Is Argenx Stock a Buy Now?
Via The Motley Fool
argenx Reports Half Year 2023 Financial Results and Provides Second Quarter Business Update
From argenx SE
Via GlobeNewswire
Earnings Outlook For argenx
Via Benzinga
argenx Unusual Options Activity
Via Benzinga
Why Shares of Argenx Jumped This Week
Via The Motley Fool
The Latest Analyst Ratings for argenx
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Via Benzinga
Argenx Stock Rides 'Megabuster' Drug Excitement To 40% Gain Before Earnings
Via Investor's Business Daily
argenx announces closing of global offering
From argenx SE
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
Via Investor's Business Daily
Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade
Via Investor's Business Daily
argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023
From argenx SE
Via GlobeNewswire
argenx announces full exercise of underwriters’ option to purchase additional ADSs
From argenx SE
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.